Research article
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
-
* Corresponding author: Francisco J Esteva festeva@mdanderson.org
Breast Cancer Research 2007, 9:R87 doi:10.1186/bcr1836
Additional data for this article
Claire Hansford (2008-11-13 14:32) BioMed Central
Due to a technical fault the additional file links have become unavailable for this article.
They are now available from:
Additional file 1: http://www.biomedcentral.com/content/
supplementary/bcr1836-S1.xls
Additional file 2: http://www.biomedcentral.com/content/
supplementary/bcr1836-S2.xls
Additional file 3: http://www.biomedcentral.com/content/
supplementary/bcr1836-S3.xls
Competing interests
None declared
top